Nicolas Boussion

Dr. Nicolas Boussion

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2021 in Cancers
Verified
Journal Article
Open access
PDF file
VBVincent Bourbonne
Vincent Bourbonne
VJVincent Jaouen
Vincent Jaouen
CHClément Hognon
Clément Hognon
NBNicolas Boussion
Nicolas Boussion
FLFrançois Lucia
François Lucia
USUlrike Schick
Ulrike Schick
Purpose: Stereotactic radiotherapy (SRT) has become widely accepted as a treatment of choice for patients with a small number of brain metastases that are of an acceptable size, allowing for better target dose conformity, resulting in high local control rates and better sparing of organs at risk. An MRI-only workflow could reduce the risk of misalignment between magnetic resonance imaging (MRI) brain studies and computed tomography (CT) scanning for SRT planning, while shortening delays in planning. Given the absence of a calibrated electronic density in MRI, we aimed to assess the equivalence of synthetic CTs generated by a generative adversarial network (GAN) for planning in the brain SRT setting. Methods: All patients with available MRIs and treated with intra-cranial SRT for brain metastases from 2014 to 2018 in our institution were included. After co-registration between the diagnostic MRI and the planning CT, a synthetic CT was generated using a 2D-GAN (2D U-Net). Using the initial treatment plan (Pinnacle v9.10, Philips Healthcare), dosimetric comparison was performed using main dose-volume histogram (DVH) endpoints in respect to ICRU 91 guidelines (Dmax, Dmean, D2%, D50%, D98%) as well as local and global gamma analysis with 1%/1 mm, 2%/1 mm and 2%/2 mm criteria and a 10% threshold to the maximum dose. t-test analysis was used for comparison between the two cohorts (initial and synthetic dose maps). Results: 184 patients were included, with 290 treated brain metastases. The mean number of treated lesions per patient was 1 (range 1–6) and the median planning target volume (PTV) was 6.44 cc (range 0.12–45.41). Local and global gamma passing rates (2%/2 mm) were 99.1 CI95% (98.1–99.4) and 99.7 CI95% (99.6–99.7) respectively (CI: confidence interval). DVHs were comparable, with no significant statistical differences regarding ICRU 91′s endpoints. Conclusions: Our study is the first to compare GAN-generated CT scans from diagnostic brain MRIs with initial CT scans for the planning of brain stereotactic radiotherapy. We found high similarity between the planning CT and the synthetic CT for both the organs at risk and the target volumes. Prospective validation is under investigation at our institution.

1 April 2024 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Closed access
GSGuillaume Sallé
Guillaume Sallé
GAGustavo Andrade-Miranda
Gustavo Andrade-Miranda
PCPierre-Henri Conze
Pierre-Henri Conze
NBNicolas Boussion
Nicolas Boussion
JBJulien Bert
Julien Bert
VJVincent Jaouen
Vincent Jaouen
Objectives : Data scarcity and domain shifts lead to biased training sets that do not accurately represent deployment conditions. A related practical problem is cross-modal image segmentation, where the objective is to segment unlabelled images using previously labelled datasets from other imaging modalities. Methods : We propose a cross-modal segmentation method based on conventional image synthesis boosted by a new data augmentation technique called Generative Blending Augmentation (GBA). GBA leverages a SinGAN model to learn representative generative features from a single training image to diversify realistically tumor appearances. This way, we compensate for image synthesis errors, subsequently improving the generalization power of a downstream segmentation model. The proposed augmentation is further combined to an iterative self-training procedure leveraging pseudo labels at each pass. Results : The proposed solution ranked first for vestibular schwannoma (VS) segmentation during the validation and test phases of the MICCAI CrossMoDA 2022 challenge, with best mean Dice similarity and average symmetric surface distance measures. Conclusion and significance : Local contrast alteration of tumor appearances and iterative self-training with pseudo labels are likely to lead to performance improvements in a variety of segmentation contexts.

14 August 2018 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Open access
VJVincent Jaouen
Vincent Jaouen
JBJulien Bert
Julien Bert
Konstantinos A MountrisKonstantinos A Mountris
Konstantinos A Mountris
NBNicolas Boussion
Nicolas Boussion
USUlrike Schick
Ulrike Schick
DVDimitris Visvikis
Dimitris Visvikis
Objective: We present a new hybrid edge and region-based parametric deformable model, or active surface, for prostate volume segmentation in transrectal ultrasound (TRUS) images. Methods: Our contribution is threefold. First, we develop a new edge detector derived from the radial bas-relief approach, allowing for better scalar prostate edge detection in low contrast configurations. Second, we combine an edge-based force derived from the proposed edge detector with a new region-based force driven by the Bhattacharyya gradient flow and adapted to the case of parametric active surfaces. Finally, we develop a quasi-automatic initialization technique for deformable models by analyzing the profiles of the proposed edge detector response radially to obtain initial landmark points towards which an initial surface model is warped. Results: We validate our method on a set of 36 TRUS images for which manual delineations were performed by two expert radiation oncologists, using a wide variety of quantitative metrics. The proposed hybrid model achieved state-of-the art segmentation accuracy. Conclusion: Results demonstrate the interest of the proposed hybrid framework for accurate prostate volume segmentation. Significance: This paper presents a modular framework for accurate prostate volume segmentation in TRUS, broadening the range of available strategies to tackle this open problem.

1 November 2008 in Clinical Nuclear Medicine
Verified
Journal Article
Closed access
NRNathalie Roudaut
Nathalie Roudaut
JMJean-Marc Malecot
Jean-Marc Malecot
EDEric Dupont
Eric Dupont
NBNicolas Boussion
Nicolas Boussion
DVDimitris Visvikis
Dimitris Visvikis
CRCatherine Cheze-Le Rest
Catherine Cheze-Le Rest

18 January 2013 in Medical Physics
Verified
Journal Article
Closed access
SBS. Benhalouche
S. Benhalouche
DVDimitris Visvikis
Dimitris Visvikis
AMA. Le Maitre
A. Le Maitre
OPO. Pradier
O. Pradier
NBNicolas Boussion
Nicolas Boussion

27 April 2016 in Physica Medica
Verified
Journal Article
Closed access
PDF file
CLCaroline Lafond
Caroline Lafond
SCSophie Chiavassa
Sophie Chiavassa
CBCindy Bertaut
Cindy Bertaut
NBNicolas Boussion
Nicolas Boussion
NCNathalie Chapel
Nathalie Chapel
GDGrégory Delpon
Grégory Delpon